How AI is streamlining cell and gene therapy manufacturing

▤ Summary

The article explains how AI is helping improve cell and gene therapy manufacturing by increasing consistency, speeding analysis, and reducing contamination risk. It highlights the need for high-quality data and shows how process analytical technology can feed machine learning and other AI models. It also describes 908 Devices’ REBEL and MAVEN systems as tools that deliver faster, real-time measurements for media composition and culture monitoring. The piece concludes that AI will support regulated biopharma workflows by improving efficiency, control, and time to market while keeping human oversight in place.

▦ Linked Companies